Enshan Hong
Associate
Associate
Areas of Expertise
Counseling on Patent Validity, Infringement, and Freedom to Operate
Conducting due diligence investigations
Patent Prosecution
Patent Litigation
Professional Summary
Mr. Hong has been practicing intellectual property law since 1996. Mr. Hong currently focuses his practice on preparation of opinions on patent validity, infringement, and freedom to operate issues, conducting due diligence investigations, counseling clients related to the Hatch-Waxman Act, prosecution of patent applications, and representing clients in reexamination, reissue and patent term extension proceedings. Mr. Hong has also been involved in a number of patent litigations. His practice covers various technologies, including chemical compounds and processes, pharmaceutical formulations, herbal extracts, cosmetic products, nutritional supplements, medical treatment and diagnosis, medical devices, polymers, food processing, petroleum processing, catalysts, inkjet inks, and semiconductor materials. Mr. Hong has counseled a diverse group of clients ranging from individual inventors to multinational corporations.
Mr. Hong joined the firm in 2002 following five years of practice as a patent attorney in China. Prior to that he worked for five years as a chemical engineer. Mr. Hong began his legal career with a Fortune 500 Company, China Petroleum and Chemical Corporation (Sinopec), where his practice focused on intellectual property management, patent prosecution, patent validity, infringement, enforcement analysis, and patent strategy.
Education
J.D. Rutgers School of Law, Newark, 2008
M.S., Intellectual Property, Franklin Pierce Law Center, 2002
B.S., Chemical Engineering, China University of Petroleum (East China), 1991
Admissions
New York
New Jersey
U.S. Patent and Trademark Office
China
State Intellectual Property Office of P.R. China
China Trademark Office
Memberships
New York Intellectual Property Law Association
Decisions
Inter parties rexamination on behalf of Gladerma R&D of Leo Pharmaceutical Products Ltd., US Patent No. 6,753,013 for TACLONEX (August 2008)
In re Metoprolol Succinate Patent Litigation, No. 2006-1254 (Fed. Cir. July 23, 2007).
Pharm. Res., Inc. v. Roxane Labs. Inc., No. 03-3357, 2006 U.S. Dist. LEXIS 81628, 2006 WL 3231427 (D.N.J. Nov. 8, 2006).
Dey LP v. IVAX Pharm. Inc., 233 F.R.D. 567 (C.D. Cal. 2005).
Mr. Hong has been practicing intellectual property law since 1996. Mr. Hong currently focuses his practice on preparation of opinions on patent validity, infringement, and freedom to operate issues, conducting due diligence investigations, counseling clients related to the Hatch-Waxman Act, prosecution of patent applications, and representing clients in reexamination, reissue and patent term extension proceedings. Mr. Hong has also been involved in a number of patent litigations. His practice covers various technologies, including chemical compounds and processes, pharmaceutical formulations, herbal extracts, cosmetic products, nutritional supplements, medical treatment and diagnosis, medical devices, polymers, food processing, petroleum processing, catalysts, inkjet inks, and semiconductor materials. Mr. Hong has counseled a diverse group of clients ranging from individual inventors to multinational corporations.
Mr. Hong joined the firm in 2002 following five years of practice as a patent attorney in China. Prior to that he worked for five years as a chemical engineer. Mr. Hong began his legal career with a Fortune 500 Company, China Petroleum and Chemical Corporation (Sinopec), where his practice focused on intellectual property management, patent prosecution, patent validity, infringement, enforcement analysis, and patent strategy.
Education
J.D. Rutgers School of Law, Newark, 2008
M.S., Intellectual Property, Franklin Pierce Law Center, 2002
B.S., Chemical Engineering, China University of Petroleum (East China), 1991
Admissions
New York
New Jersey
U.S. Patent and Trademark Office
China
State Intellectual Property Office of P.R. China
China Trademark Office
Memberships
New York Intellectual Property Law Association
Decisions
Inter parties rexamination on behalf of Gladerma R&D of Leo Pharmaceutical Products Ltd., US Patent No. 6,753,013 for TACLONEX (August 2008)
In re Metoprolol Succinate Patent Litigation, No. 2006-1254 (Fed. Cir. July 23, 2007).
Pharm. Res., Inc. v. Roxane Labs. Inc., No. 03-3357, 2006 U.S. Dist. LEXIS 81628, 2006 WL 3231427 (D.N.J. Nov. 8, 2006).
Dey LP v. IVAX Pharm. Inc., 233 F.R.D. 567 (C.D. Cal. 2005).
